Skip to main content
Log in

High Level of Residual Symptoms in Young Patients After Total Knee Arthroplasty

  • Symposium: 2013 Knee Society Proceedings
  • Published:
Clinical Orthopaedics and Related Research®

Abstract

Background

TKA is among the fastest growing interventions in medicine, with procedure incidence increasing the most in younger patients. Global knee scores have a ceiling effect and do not capture the presence of difficulty or dissatisfaction with specific activities important to patients.

Questions/purposes

We quantified the degree of residual symptoms and specific functional deficits in young patients who had undergone TKA.

Methods

In a national multicenter study, we quantified the degree of residual symptoms and specific functional deficits in 661 young patients (mean age, 54 years; range, 19–60 years; 61% female) at 1 to 4 years after primary TKA. To eliminate observer bias, satisfaction and function data were collected by an independent, third-party survey center with expertise in administering medical outcomes questionnaires for federal agencies.

Results

Overall, 89% of patients were satisfied with their ability to perform normal daily living activities, and 91% were satisfied with their pain relief. After TKA, 66% of patients indicated their knees felt normal, 33% reported some degree of pain, 41% reported stiffness, 33% reported grinding/other noises, 33% reported swelling/tightness, 38% reported difficulty getting in and out of a car, 31% reported difficulty getting in and out of a chair, and 54% reported difficulty with stairs. After recovery, 47% reported complete absence of a limp and 50% had participated in their most preferred sport or recreational activity in the past 30 days.

Conclusions

When interviewed by an independent third party, about 1/3 of young patients reported residual symptoms and limitations after modern TKA. We recommend informing patients considering surgery about the high likelihood of residual symptoms and limitations after contemporary TKA, even when performed by experienced surgeons in high-volume centers, and taking specific steps to set patients’ expectations to a level that is likely to be met by the procedure as it now is performed.

Level of Evidence

Level III, therapeutic study. See Instructions for Authors for a complete description of levels of evidence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Barrack RL, Ruh EL, Chen J, Lombardi AV Jr, Berend KR, Parvizi J, Della Valle CJ, Hamilton WG, Nunley RM. Impact of socioeconomic factors on outcome of total knee arthroplasty. Clin Orthop Relat Res. 2013 April 30 [Epub ahead of print].

  2. Bonnin MP, Basiglini L, Archbold HA. What are the factors of residual pain after uncomplicated TKA? Knee Surg Sports Traumatol Arthrosc. 2011;19:1411–1417.

    Article  PubMed  Google Scholar 

  3. Bourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KD. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010;468:57–63.

    Article  PubMed Central  PubMed  Google Scholar 

  4. Chatman AB, Hyams SP, Neel JM, Binkley JM, Stratford PW, Schomberg A, Stabler M. The Patient-Specific Functional Scale: measurement properties in patients with knee dysfunction. Phys Ther. 1997;77:820–829.

    CAS  PubMed  Google Scholar 

  5. Gandhi R, Santone D, Takahashi M, Dessouki O, Mahomed NN. Inflammatory predictors of ongoing pain 2 years following knee replacement surgery. Knee. 2012 November 14 [Epub ahead of print].

  6. Horn KK, Jennings S, Richardson G, Vliet DV, Hefford C, Abbott JH. The Patient-Specific Functional Scale: psychometrics, clinimetrics, and application as a clinical outcome measure. J Orthop Sports Phys Ther. 2012;42:30–42.

    Article  PubMed  Google Scholar 

  7. Likert R. A technique for the measurement of attitudes. Arch Psychol. 1932;140:5–55.

    Google Scholar 

  8. Lützner J, Hübel U, Kirschner S, Günther KP, Krummenauer F. [Long-term results in total knee arthroplasty: a meta-analysis of revision rates and functional outcome] [in German]. Chirurg. 2011;82:618–624.

    Article  PubMed  Google Scholar 

  9. Noble PC, Conditt MA, Cook KF, Mathis KB. The John Insall Award. Patient expectations affect satisfaction with total knee arthroplasty. Clin Orthop Relat Res. 2006;452:35–43.

    Article  PubMed  Google Scholar 

  10. Papakostidou I, Dailiana ZH, Papapolychroniou T, Liaropoulos L, Zintzaras E, Karachalios TS, Malizos KN. Factors affecting the quality of life after total knee arthroplasties: a prospective study. BMC Musculoskelet Disord. 2012;13:116.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Pitman MI, Nainzadeh N, Menche D, Gasalberti R, Song EK. The intraoperative evaluation of the neurosensory function of the anterior cruciate ligament in humans using somatosensory evoked potentials. Arthroscopy. 1992;8:442–447.

    Article  CAS  PubMed  Google Scholar 

  12. Scott CE, Howie CR, MacDonald D, Biant LC. Predicting dissatisfaction following total knee replacement: a prospective study of 1217 patients. J Bone Joint Surg Br. 2010;92:1253–1258.

    Article  CAS  PubMed  Google Scholar 

  13. Singh JA, O’Byrne M, Harmsen S, Lewallen D. Predictors of moderate-severe functional limitation after primary total knee arthroplasty (TKA): 4701 TKAs at 2-years and 2935 TKAs at 5-years. Osteoarthritis Cartilage. 2010;18:515–521.

    Article  CAS  PubMed  Google Scholar 

  14. Wegener JT, van Ooij B, van Dijk CN, Karayeva SA, Hollmann MW, Preckel B, Stevens MF. Long-term pain and functional disability after total knee arthroplasty with and without single-injection or continuous sciatic nerve block in addition to continuous femoral nerve block: a prospective, 1-year follow-up of a randomized controlled trial. Reg Anesth Pain Med. 2013;38:58–63.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Javad Parvizi MD, FRCS.

Additional information

The institution of one or more of the authors has received, during the study period, funding from 3 M (St Paul, MN, USA) (JP), Baxter Healthcare Corp (Deerfield, IL, USA) (JP), Biomet Inc (Warsaw, IN, USA) (RLB, AVL, KRB, WGH, RMN), DePuy Orthopaedics, Inc, a Johnson and Johnson company (Warsaw, IN, USA) (JP, WGH), EOS Imaging Inc (Cambridge, MA, USA) (RLB, RMN), Inova Health Care Services (Falls Church, VA, USA) (WGH), Medical Compression Systems, Inc (West Hills, CA, USA) (RLB, RMN), Musculoskeletal Transplant Foundation (Edison, NJ, USA) (JP), NIH (Bethesda, MD, USA) (RLB, JP), Smith & Nephew, Inc (Memphis, TN, USA) (RLB, JP, CDV, RMN), Stryker Orthopaedics (Mahwah, NJ, USA) (RLB, AVL, JP, CDV, RMN), Wright Medical Technology, Inc (Arlington, TN, USA) (RLB, RMN), and Zimmer Inc (Warsaw, IN, USA) (JP). The institutions of the authors have received funding from Stryker Orthopaedics in support of this study.

One of the authors certifies that he (JP) has received or may receive payments or benefits, during the study period, an amount of USD 10,000 to 100,000 from Smith & Nephew, Inc, an amount of USD 10,000 to 100,000 from 3 M, an amount of USD 10,000 to 100,000 from Cadence Pharmaceuticals, Inc (San Diego, CA, USA), an amount of USD 10,000 to 100,000 from CeramTec (Laurens, SC, USA), an amount of USD 10,000 to 100,000 from Pfizer (New York, NY, USA), an amount of USD 10,000 to 100,000 from Salient Surgical (Minneapolis, MN, USA), an amount of USD 10,000 to 100,000 from TissueGene (Rockville, MD, USA), and an amount of USD 10,000 to 100,000 from Zimmer Inc.

One of the authors certifies that he (RMN) has received or may receive payments or benefits, during the study period, an amount of less than USD 10,000 from Smith & Nephew, Inc, an amount of less than USD 10,000 from Wright Medical Technology, Inc, an amount of less than USD 10,000 from Medtronic (Minneapolis, MN, USA), an amount of less than USD 10,000 from CardioMEMS (Atlanta, GA, USA), and an amount of less than USD 10,000 from Integra LifeSciences (Plainsboro, NJ, USA).

One of the authors certifies that he (KRB) has received or may receive payments or benefits, during the study period, an amount of USD 100,001 to USD 1,000,000, from Biomet, Inc.

One of the authors certifies that he (AVL) has received or may receive payments or benefits, during the study period, an amount of more than USD 1,000,001 from Biomet Inc, and an amount of USD 10,000 to 100,000 from Innomed, Inc (Savannah, GA, USA).

One of the authors certifies that he (WGH) has received or may receive payments or benefits, during the study period, an amount of USD 100,001 to 1,000,000 from DePuy, a Johnson and Johnson company, and an amount of USD 10,000 to 100,000 from Medtronic.

One of the authors certifies that he (CJD) has received or may receive payments or benefits, during the study period, an amount of USD 10,000 to USD 100,000 from Biomet, Inc, an amount of USD 10,000 to USD 100,000 from CD Diagnostics (Wynnewood, PA, USA), an amount of less than USD 10,000 from ConvaTec (Skillman, NJ, USA), an amount of USD 10,000 to USD 100,000 from Smith & Nephew, Inc, and an amount of USD 10,000 to USD 100,000 from Stryker Orthopaedics.

One of the authors certifies that he (RLB) has received or may receive payments or benefits, during the study period, an amount of more than USD 1,000,001 from Smith & Nephew, Inc, and an amount of more than USD 1,000,001 from Stryker Orthopaedics.

All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research editors and board members are on file with the publication and can be viewed on request.

Clinical Orthopaedics and Related Research neither advocates nor endorses the use of any treatment, drug, or device. Readers are encouraged to always seek additional information, including FDA approval status, of any drug or device before clinical use.

Each author certifies that his or her institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.

This work was performed at Washington University School of Medicine (St Louis, MO, USA), Joint Implant Surgeons, Inc (New Albany, OH, USA), Rothman Institute of Orthopedics at Thomas Jefferson University (Philadelphia, PA, USA), Midwest Orthopaedics at Rush (Chicago, IL, USA), and Anderson Orthopaedic Clinic (Arlington, VA, USA).

Appendix 1

Appendix 1

Telephone Questionnaire: Outcomes of Interest (Residual Symptoms)

Satisfaction Section

  1. 1.

    Since you had the operation on your (left/right) knee, are you satisfied, dissatisfied, or in-between with the overall functioning of your knee?

    If “in-between”: Do you lean more toward satisfied or dissatisfied?

  2. 2.

    Since you had the operation on your (left/right) knee, are you satisfied with your ability to perform your normal activities of daily living?

  3. 3.

    Since you had the operation on your (left/right) knee, are you satisfied with the degree of pain relief?

  4. 4.

    Do you have problems getting in and out of a car?

    Never, rarely, sometimes, often, or extremely often

  5. 5.

    Do you have problems getting in and out of a chair?

    Never, rarely, sometimes, often, or extremely often

  6. 6.

    How difficult is it for you to go up and down stairs because of the operation on your knee?

    Not at all difficult, a little difficult, somewhat difficult, quite difficult, very difficult, or extremely difficult

  7. 7.

    In the last 30 days, about how often did you experience any pain in your (left/right) knee?

    Never, rarely, sometimes, often, or extremely often

  8. 8.

    In the last 30 days, about how often did you experience any swelling or a sense of tightness in your (left/right) knee?

    Never, rarely, sometimes, often, or extremely often

    In the last 30 days, about how often did you experience any stiffness in your (left/right) knee?

    Never, rarely, sometimes, often, or extremely often

    In the last 30 days, about how often did you experience grinding or popping or hear clicking or other noises in your (left/right) knee?

    Never, rarely, sometimes, often, or extremely often

  9. 9.

    In the last 30 days, about how often did you experience any stiffness in your (left/right) knee?

    Never, rarely, sometimes, often, or extremely often

  10. 10.

    In the last 30 days, about how often did you experience grinding or popping or hear clicking or other noises in your (left/right) knee?

    Never, rarely, sometimes, often, or extremely often

  11. 11.

    Does your (left/right) knee that was operated on feel normal to you?

Activity Section

  1. 12.

    How often do you limp while walking?

    Never, rarely, sometimes, very often, or extremely often

Patient-Specific Functional Scale–Sports/Hobby Section

  1. 13.

    During the last 30 days, how often did you (do/play/etc) Activity 1?

About this article

Cite this article

Parvizi, J., Nunley, R.M., Berend, K.R. et al. High Level of Residual Symptoms in Young Patients After Total Knee Arthroplasty. Clin Orthop Relat Res 472, 133–137 (2014). https://doi.org/10.1007/s11999-013-3229-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-013-3229-7

Keywords

Navigation